Literature DB >> 19265439

Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.

Arup Maiti1, P V Narasimha Reddy, Megan Sturdy, Laura Marler, Scott D Pegan, Andrew D Mesecar, John M Pezzuto, Mark Cushman.   

Abstract

An efficient method has been developed to synthesize casimiroin (1), a component of the edible fruit of Casimiroa edulis, on a multigram scale in good overall yield. The route was versatile enough to provide an array of compound 1 analogues that were evaluated as QR2 and aromatase inhibitors. In addition, X-ray crystallography studies of QR2 in complex with compound 1 and one of its more potent analogues has provided insight into the mechanism of action of this new series of QR2 inhibitors. The initial biological investigations suggest that compound 1 and its analogues merit further investigation as potential chemopreventive or chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19265439      PMCID: PMC2673050          DOI: 10.1021/jm801335z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

1.  SRS-A antagonist pyranoquinolone alkaloids from east African Fagara plants and their synthesis.

Authors:  T Kamikawa; Y Hanaoka; S Fujie; K Saito; Y Yamagiwa; K Fukuhara; I Kubo
Journal:  Bioorg Med Chem       Date:  1996-08       Impact factor: 3.641

Review 2.  Molecular tools to study melatonin pathways and actions.

Authors:  Jean A Boutin; Valérie Audinot; Gilles Ferry; Philippe Delagrange
Journal:  Trends Pharmacol Sci       Date:  2005-08       Impact factor: 14.819

Review 3.  NRH:quinone reductase 2: an enzyme of surprises and mysteries.

Authors:  Fanny Vella; Gilles Ferry; Philippe Delagrange; Jean A Boutin
Journal:  Biochem Pharmacol       Date:  2005-10-25       Impact factor: 5.858

4.  Crystal structure of human quinone reductase type 2, a metalloflavoprotein.

Authors:  C E Foster; M A Bianchet; P Talalay; Q Zhao; L M Amzel
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

5.  Quinone reductase 2 substrate specificity and inhibition pharmacology.

Authors:  Jean A Boutin; Florence Chatelain-Egger; Fanny Vella; Philippe Delagrange; Gilles Ferry
Journal:  Chem Biol Interact       Date:  2005-02-10       Impact factor: 5.192

6.  NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.

Authors:  Claudia M Celli; Namphuong Tran; Richard Knox; Anil K Jaiswal
Journal:  Biochem Pharmacol       Date:  2006-05-04       Impact factor: 5.858

7.  Miliusanes, a class of cytotoxic agents from Miliusa sinensis.

Authors:  Hong-Jie Zhang; Cuiying Ma; Van Hung Nguyen; Manh Cuong Nguyen; Ghee Teng Tan; Bernard D Santarsiero; Andrew D Mesecar; D Doel Soejarto; John M Pezzuto; Harry H S Fong
Journal:  J Med Chem       Date:  2006-01-26       Impact factor: 7.446

8.  Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.

Authors:  Yue Fu; Leonid Buryanovskyy; Zhongtao Zhang
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

9.  Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer.

Authors:  Arup Maiti; Muriel Cuendet; Vicki L Croy; Denise C Endringer; John M Pezzuto; Mark Cushman
Journal:  J Med Chem       Date:  2007-05-19       Impact factor: 7.446

10.  Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.

Authors:  D Jamieson; A T Y Tung; R J Knox; A V Boddy
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

View more
  18 in total

1.  Neoflavonoids and tetrahydroquinolones as possible cancer chemopreventive agents.

Authors:  Suaib Luqman; Abha Meena; Pragya Singh; Tamara P Kondratyuk; Laura E Marler; John M Pezzuto; Arvind S Negi
Journal:  Chem Biol Drug Des       Date:  2012-07-25       Impact factor: 2.817

Review 2.  Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.

Authors:  Debashis Ghosh; Jessica Lo; Chinaza Egbuta
Journal:  J Med Chem       Date:  2016-01-19       Impact factor: 7.446

3.  Bioactive compounds from the fern Lepisorus contortus.

Authors:  Jian-Hong Yang; Tamara P Kondratyuk; Katherine C Jermihov; Laura E Marler; Xi Qiu; Yongsoo Choi; Hongmei Cao; Rui Yu; Megan Sturdy; Rong Huang; Ying Liu; Li-Qin Wang; Andrew D Mesecar; Richard B van Breemen; John M Pezzuto; Harry H S Fong; Ye-Gao Chen; Hong-Jie Zhang
Journal:  J Nat Prod       Date:  2011-01-24       Impact factor: 4.050

4.  Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.

Authors:  Kevin Bonfield; Erica Amato; Tony Bankemper; Hannah Agard; Jeffrey Steller; James M Keeler; David Roy; Adam McCallum; Stefan Paula; Lili Ma
Journal:  Bioorg Med Chem       Date:  2012-02-27       Impact factor: 3.641

5.  Dirhodium-catalyzed C-H arene amination using hydroxylamines.

Authors:  Mahesh P Paudyal; Adeniyi Michael Adebesin; Scott R Burt; Daniel H Ess; Zhiwei Ma; László Kürti; John R Falck
Journal:  Science       Date:  2016-09-09       Impact factor: 47.728

6.  Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.

Authors:  P V Narasimha Reddy; Katherine C Jensen; Andrew D Mesecar; Phillip E Fanwick; Mark Cushman
Journal:  J Med Chem       Date:  2011-12-29       Impact factor: 7.446

7.  Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS.

Authors:  Yongsoo Choi; Katherine Jermihov; Sang-Jip Nam; Megan Sturdy; Katherine Maloney; Xi Qiu; Lucas R Chadwick; Matthew Main; Shao-Nong Chen; Andrew D Mesecar; Norman R Farnsworth; Guido F Pauli; William Fenical; John M Pezzuto; Richard B van Breemen; Richard R van Breemen
Journal:  Anal Chem       Date:  2010-12-30       Impact factor: 6.986

8.  Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.

Authors:  Chao Yan; Marine Dufour; David Siegel; Philip Reigan; Joe Gomez; Biehuoy Shieh; Christopher J Moody; David Ross
Journal:  Biochemistry       Date:  2011-07-19       Impact factor: 3.162

9.  X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.

Authors:  Scott D Pegan; Megan Sturdy; Gilles Ferry; Philippe Delagrange; Jean A Boutin; Andrew D Mesecar
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

10.  Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.

Authors:  Erica Amato; Tony Bankemper; Rebecca Kidney; Thuy Do; Alma Onate; Fathima Shazna Thowfeik; Edward J Merino; Stefan Paula; Lili Ma
Journal:  Bioorg Med Chem       Date:  2013-12-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.